Atezolizumab Plus One-year BCG Bladder Instillation in BCG-naive High-risk Non-muscle Invasive Bladder Cancer Patients
Clinical trial NCT03799835 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03799835
- Sponsor
- UNICANCER
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-17
- Primary completion
- 2025-06-01
- Enrollment
- 517
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.